Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
Dysphagia ; 37(6): 1757-1768, 2022 12.
Article in English | MEDLINE | ID: mdl-35415813

ABSTRACT

We examined factors related to dietary intake status (food form) of long-term care facility (LTCF) residents to identify factors related to proper food form choice for older individuals requiring nursing care. We surveyed 888 residents from 37 LTCFs in Japan. We evaluated basic information (age, sex, body mass index [BMI]), food form (swallowing-adjusted diet class), Barthel Index (BI), Clinical Dementia Rating (CDR), simply evaluated eating and swallowing functions, the number of present/functional teeth, oral diadochokinesis, repetitive saliva swallowing test (RSST), and modified water swallowing test. To clarify factors associated with food form, participants who had good nutrition by oral intake were categorized into the dysphagic diet (DD) and normal diet (ND) groups. Multi-level analyses were used to detect oral functions associated with food form status. Among objective assessments, BMI (odds ratio [OR] 0.979, 95% confidence interval [CI] - 0.022- to 0.006, p = 0.001), BI (OR 0.993, 95% CI - 0.007 to - 0.004, p < 0.001), CDR 3.0 (OR 1.002, 95% CI 0.002‒0.236, p = 0.046), present teeth (OR 0.993, 95% CI - 0.007 to - 0.001, p = 0.011), functional teeth (OR 0.989, 95% CI - 0.011 to - 0.005, p < 0.001), and RSST (OR 0.960, 95% CI - 0.041 to - 0.007, p = 0.006) were significantly associated with DD vs ND discrimination. Simple evaluations of coughing (OR 1.056, 0.054‒0.198, p = 0.001) and rinsing (OR 1.010, 0.010‒0.174, p = 0.029) could also discriminate food form status. These simple evaluations provide insight into the discrepancies between food form status and eating abilities of LTCF residents. Periodic evaluations by the nursing caregiver may help to prevent aspiration by older individuals with dysphagia.


Subject(s)
Deglutition Disorders , Insurance, Long-Term Care , Humans , Deglutition , Deglutition Disorders/diagnosis , Nutritional Status , Eating , Long-Term Care
2.
Jpn Dent Sci Rev ; 58: 52-58, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35140822

ABSTRACT

The National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) is a database including health insurance claim and specific health checkup data. Observational studies using real-world big data attract attention because they have certain strengths, including external validity and a large sample size. This review focused on research using the dental formula of the NDB because the number of teeth is an important indicator of oral health. The number of teeth present calculated using the dental formula of periodontitis patients was similar to that from the Survey of Dental Diseases. In addition, the graphs of the presence rates of tooth types by 5-year age groups from the NDB were smoother and had less overlap than those from the Survey of Dental Diseases, and they could detect slight changes in the presence rate that reflected sugar consumption before and after World War II. Using the NDB, a low number of teeth was associated with high medical care expenditures, high risk of aspiration pneumonia, and high risk of Alzheimer's disease. Although there are some restrictions on the use of the NDB, we hope that dental research using the NDB will be further promoted in the future.

3.
PLoS One ; 16(4): e0251056, 2021.
Article in English | MEDLINE | ID: mdl-33930067

ABSTRACT

Associations of numbers of teeth present and of missing teeth with Alzheimer's disease were cross-sectionally analyzed using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Dental care claims data of patients aged 60 years or older diagnosed with periodontitis (n = 4,009,345) or missing teeth (n = 662,182) were used to obtain information about the numbers of teeth present and of missing teeth, respectively, and they were combined with medical care claims data including the diagnosis of Alzheimer's disease. Numbers of teeth present and of missing teeth excluding third molars were calculated using the dental formula in the claims for periodontitis and missing teeth, respectively, and categorized into three groups each. Percentages of subjects treated for Alzheimer's disease with 20-28, 10-19, and 1-9 teeth present were 1.95%, 3.87%, and 6.86%, respectively, in patients diagnosed as having periodontitis, and those treated for Alzheimer's disease with 1-13, 14-27, and 28 missing teeth were 2.67%, 5.51%, and 8.70%, respectively, in patients diagnosed as having missing teeth. Logistic regression models using treatment for Alzheimer's disease as an outcome variable and adjusting for age and sex showed that odds ratios (95% confidence intervals) for patients with 10-19 and 1-9 teeth (reference: 20-28 teeth) were 1.11 (1.10-1.13) and 1.34 (1.32-1.37), respectively, (p<0.001), in patients diagnosed as having periodontitis, and odds ratios (95% confidence intervals) for patients with 14-27 missing teeth and 28 missing teeth (reference: 1-13 missing teeth) were 1.40 (1.36-1.44) and 1.81 (1.74-1.89), respectively, (p<0.001), in patients diagnosed as having missing teeth. In conclusion, the results of the present study using Japanese dental claims data showed that older people visiting dental offices with fewer teeth present and a greater number of missing teeth are more likely to have Alzheimer's disease.


Subject(s)
Alzheimer Disease/epidemiology , Diagnosis, Oral/methods , Insurance Claim Review/statistics & numerical data , Insurance, Health/statistics & numerical data , Periodontitis/physiopathology , Tooth Loss/physiopathology , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Databases, Factual , Female , Humans , Japan/epidemiology , Logistic Models , Male , Middle Aged
4.
Intern Med ; 60(3): 423-429, 2021 Feb 01.
Article in English | MEDLINE | ID: mdl-32963156

ABSTRACT

We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed increased levels of interleukin (IL)-8, monocyte chemotactic and activating factor, and granulocyte macrophage colony-stimulating factor (GM-CSF) when he developed Takotsubo cardiomyopathy. Case 2 with subclinical myocarditis showed predominant activation of IL-8 during the progressive clinical course. Case 3 with cytokine-releasing syndrome showed substantial activations of IL-6, IL-8, GM-CSF, and interferon-γ. Our data suggest the development of unique cytokine activation in individual patients with cardiac complications after ICI therapy.


Subject(s)
Cytokines , Immune Checkpoint Inhibitors , Granulocyte-Macrophage Colony-Stimulating Factor , Humans , Interferon-gamma , Male , Monocytes
6.
Nihon Kokyuki Gakkai Zasshi ; 46(9): 743-7, 2008 Sep.
Article in Japanese | MEDLINE | ID: mdl-18939419

ABSTRACT

A 55-year-old woman who developed severe hypoxemia associated with severe pneumonia was admitted to our hospital for mechanical ventilation. She was treated with antibiotics under a diagnosis of mycoplasma pneumonia. Although most clinical findings improved, hypoxemia remained. As a chest CT film showed multiple nodules and an enhanced CT film revealed arterial filling in the nodules, multiple pulmonary arteriovenous fistulas (PAVFs) were considered to be an underlying cause of hypoxemia. Transcatheter coil embolization for 5 PAVFs, significantly ameliorated hypoxemia in the patient. PAVF is a congenital desease, and in many cases, is asymptomatic. Therefore, it was rare for PAVFs to be detected in a middle-aged patient with prolonged hypoxemia associated with pneumonia.


Subject(s)
Arteriovenous Fistula/complications , Arteriovenous Fistula/diagnostic imaging , Pneumonia, Mycoplasma/etiology , Pulmonary Artery/abnormalities , Pulmonary Veins/abnormalities , Arteriovenous Fistula/therapy , Embolization, Therapeutic , Female , Humans , Hypoxia/etiology , Middle Aged , Radiography , Severity of Illness Index , Treatment Outcome
7.
Pulm Pharmacol Ther ; 21(5): 774-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18571961

ABSTRACT

BACKGROUND: Persistent neutrophil influx into the airways is a characteristic of chronic respiratory infection and contributes to the deterioration of pulmonary function. Ghrelin is a novel growth hormone (GH)-releasing peptide with potential anti-inflammatory activities. The present study investigated whether or not ghrelin can reduce neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. POPULATIONS AND METHODS: Synthesized ghrelin was administered intravenously for 3 weeks to 7 cachectic patients with chronic respiratory infection to confirm ghrelin's effects on airway inflammation and nutrition state. Neutrophils, neutrophil products and inflammatory cytokines in sputum were used as markers of airway inflammation. Changes in serum protein levels were also evaluated along with plasma catecholamine levels. Exercise tolerance was assessed by measuring 6-min walking distance before and after 3 weeks of ghrelin treatment. RESULTS: Three-week ghrelin administration decreased neutrophil density and inflammatory cytokine levels in sputum, reduced plasma norepinephrine level, and increased body weight, serum protein level, and 6-min walking distance. CONCLUSIONS: Ghrelin administration suppressed airway inflammation by decreasing neutrophil accumulation in lungs and increased body weight. These findings may contribute to the development of supportive therapies for patients with refractory chronic respiratory infection.


Subject(s)
Bronchitis/drug therapy , Ghrelin/therapeutic use , Neutrophils/drug effects , Respiratory Tract Infections/drug therapy , Aged , Aged, 80 and over , Blood Proteins/metabolism , Body Weight/drug effects , Bronchitis/immunology , Chronic Disease , Cytokines/metabolism , Eating/drug effects , Exercise Tolerance/drug effects , Female , Haemophilus influenzae/isolation & purification , Humans , Male , Middle Aged , Neutrophils/immunology , Neutrophils/metabolism , Norepinephrine/blood , Oxygen/blood , Pseudomonas aeruginosa/isolation & purification , Respiratory Tract Infections/immunology , Respiratory Tract Infections/microbiology , Sputum/chemistry , Sputum/drug effects , Sputum/microbiology
8.
Nihon Kokyuki Gakkai Zasshi ; 46(4): 308-13, 2008 Apr.
Article in Japanese | MEDLINE | ID: mdl-18516995

ABSTRACT

We here report a case of metastasis from lung cancer to the thyroid. On presentation, this patient showed painful anterior cervical swelling and right supraclavicular lymph node swelling. Laboratory data showed primary hyperthyroidism. Although subacute thyroiditis was suspected, echo-guided needle aspiration biopsy and lymph node biopsy revealed poorly differentiated squamous cell carcinoma. As a result, primary lung cancer with thyroid metastasis was diagnosed based on mediastinal enlargement on chest X ray films and normal findings in organs other than the lung and thyroid. Chemotherapy for lung cancer induced a decrease in the size of tumor and the normalization of thyroid function. However, 2 months after the normalization, cervical swelling enlarged and a lung mass in right upper lobe and skin tumor appeared. Despite treatment with chemotherapy, she died. Postmortem revealed that the right upper lung carcinoma was the primary lesion and immunohistochemical staining for surfactant protein was positive in the thyroid, skin tumor and lymph node, which revealed these carcinomas had metastasized from lung cancer. To the best of our knowledge, thyrotoxicosis induced by thyroid metastasis of lung cancer is an uncommon case.


Subject(s)
Carcinoma, Squamous Cell/complications , Hyperthyroidism/etiology , Lung Neoplasms/complications , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/pathology , Female , Humans , Incidental Findings , Lung Neoplasms/diagnosis , Lung Neoplasms/pathology , Middle Aged , Thyroid Neoplasms/secondary
9.
Nihon Kokyuki Gakkai Zasshi ; 45(1): 49-53, 2007 Jan.
Article in Japanese | MEDLINE | ID: mdl-17313027

ABSTRACT

A 73-year-old man was referred to our hospital because of left chest pain, left pleural effusion and peripheral blood eosinophilia. After three months, left pleural effusion resolved without treatment and the etiology remained unclarified. Three years later, he was admitted for evaluation of right pleural effusion. Peripheral blood eosinophil count and serum IgE value were elevated. Eosinophilia was also observed in the pleural effusion. The diagnosis of paragonimiasis westermani was confirmed by immunoserological examination of the serum and by detection of Paragonimius eggs in the pleural effusion. Two cycles of treatment with praziquantel were effective in this case. When a patient has repeated pleural effusion, paragonimiasis should be considered in the differential diagnosis.


Subject(s)
Lung Diseases, Parasitic/diagnosis , Paragonimiasis/diagnosis , Paragonimus westermani/isolation & purification , Parasite Egg Count , Pleural Effusion/etiology , Pleural Effusion/parasitology , Aged , Animals , Anthelmintics/therapeutic use , Drug Administration Schedule , Humans , Lung Diseases, Parasitic/drug therapy , Male , Paragonimiasis/drug therapy , Praziquantel/therapeutic use
10.
Nihon Kokyuki Gakkai Zasshi ; 45(1): 71-5, 2007 Jan.
Article in Japanese | MEDLINE | ID: mdl-17313031

ABSTRACT

A 74-year-old smoking man was admitted because of lung cancer with metastatic brain tumor. Examinations for lung cancer and brain tumor showed adenocarcinoma (clinical stage IV). Four courses of chemotherapy were not effective. Administration of gefitinib started from June 2003, but was halted after only two months because of skin rash. Lung tumor disappeared on chest computerized tomography in January 2004 and no recurrence has been detected as of March 2006. This is a rare male super-responder to gefitinib.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/administration & dosage , Lung Neoplasms/drug therapy , Quinazolines/administration & dosage , Adenocarcinoma/secondary , Aged , Brain Neoplasms/secondary , Brain Neoplasms/surgery , Drug Administration Schedule , Gefitinib , Humans , Lung Neoplasms/pathology , Male , Neoplasm Staging , Radiosurgery , Remission Induction , Smoking
SELECTION OF CITATIONS
SEARCH DETAIL